Medicus Sciences Acquisition News Today

Medicus Sciences Acquisition Corp. Announces Liquidation New York, New York, February 13, 2023 - Medicus Sciences Acquisition Corp. , announced today that due to its inability... | February 13, 2023

Medicus Sciences Acquisition Corp. (NASDAQ:MSAC – Get Rating) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,800 shares, a decline of 99.4% from the March 15th total of 301,800 shares. Currently, 0.0% of the company’s stock are short sold. Based on an […]

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has received a proposal to merge with NASDAQ-listed special purpose acquisition company Medicus Sciences...

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has received a proposal to merge with NASDAQ-listed special purpose acquisition company Medicus Sciences...

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF)s Wayne Paterson provides an overview of a proposal thats landed on the companys desk, which asks it to...

Share this article Share this article NEW YORK, April 1, 2021 /PRNewswire/ -- Medicus Sciences Acquisition Corp. (the "Company," or "MSAC") announced that, commencing April 5, 2021 (the "Unit Separation Date"), the units sold in the Companys initial public offering (the "Units") will no longer trade, and that the Companys Class A ordinary shares (the "Class A Ordinary Shares") and the Companys redeemable warrants (the "Redeemable Warrants") which together comprise the Units will commence tradi...

/PRNewswire/ -- Medicus Sciences Acquisition Corp. (the "Company," or "MSAC") announced today the closing of its initial public offering of 9,200,000 units,...